The Biden administration has a new plan to help fight the growing monkeypox outbreak with dwindling vaccine supplies. The FDA has expanded its authorization for the vaccine, allowing healthcare providers to inject one-fifth of a typical dose into each patient. Dr. Amesh Adalja, an infectious disease specialist and senior scholar at the Johns Hopkins University Center for Health Security, joined Cheddar News to explain the science behind the new strategy, and how it might help contain the worsening outbreak. "So, there has not been a really smooth or great rollout of this vaccine. But the other point is that we just don't have a lot of it. So we have to be innovative. We have to think about prioritizing the first doses."